These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2526738

  • 1. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
    Hivroz C, Vallé A, Brouet JC, Banchereau J, Grillot-Courvalin C.
    Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
    [Abstract] [Full Text] [Related]

  • 2. The Fc epsilon R2/CD23 antigen: a hallmark of chronic lymphocytic leukemia B cells.
    Almerigogna F, Biagiotti R, Giudizi MG, Alessi A, Ricci M, Bosi A, Romagnani S.
    Ric Clin Lab; 1989 Jun; 19(2):129-38. PubMed ID: 2528201
    [Abstract] [Full Text] [Related]

  • 3. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
    Galizzi JP, Cabrillat H, Rousset F, Ménétrier C, de Vries JE, Banchereau J.
    J Immunol; 1988 Sep 15; 141(6):1982-8. PubMed ID: 2844892
    [Abstract] [Full Text] [Related]

  • 4. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
    Prinz JC, Baur X, Mazur G, Rieber EP.
    Eur J Immunol; 1990 Jun 15; 20(6):1259-64. PubMed ID: 2142456
    [Abstract] [Full Text] [Related]

  • 5. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
    Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M.
    J Clin Invest; 1992 Apr 15; 89(4):1312-21. PubMed ID: 1532590
    [Abstract] [Full Text] [Related]

  • 6. Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4.
    Kawabe T, Maekawa N, Maeda Y, Hosoda M, Yodoi J.
    J Immunol; 1991 Jul 15; 147(2):548-53. PubMed ID: 1830067
    [Abstract] [Full Text] [Related]

  • 7. Expression of CD23 antigen is not necessary for human 12-kDa B cell growth factor-mediated B cell proliferation.
    Vazquez A, Mills S, Sharma S, Maizel AL.
    Eur J Immunol; 1988 Oct 15; 18(10):1647-9. PubMed ID: 2973416
    [Abstract] [Full Text] [Related]

  • 8. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC, Brière F, Zurawski G, Bridon JM, Banchereau J.
    Immunology; 1994 Nov 15; 83(3):397-403. PubMed ID: 7530690
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M, Sundström C, Bengtsson M, Tötterman TH, Rosén A, Nilsson K.
    Eur J Immunol; 1989 May 15; 19(5):913-21. PubMed ID: 2525477
    [Abstract] [Full Text] [Related]

  • 10. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
    Defrance T, Vanbervliet B, Durand I, Banchereau J.
    Eur J Immunol; 1989 Feb 15; 19(2):293-9. PubMed ID: 2467815
    [Abstract] [Full Text] [Related]

  • 11. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F, Malefijt RW, Slierendregt B, Aubry JP, Bonnefoy JY, Defrance T, Banchereau J, de Vries JE.
    J Immunol; 1988 Apr 15; 140(8):2625-32. PubMed ID: 2965726
    [Abstract] [Full Text] [Related]

  • 12. IL-6 augments Fc IgE receptor (Fc epsilon RII/CD23) expression on human monoblastic/monocytic cell lines U937, THP-1, and Mono-Mac-6 but not on blood monocytes. Regulatory effects of IL-4 and IFN-gamma.
    Willheim M, Gessl A, Berger R, Schedle A, Luger T, Föster O, Boltz-Nitulescu G.
    J Immunol; 1991 Sep 15; 147(6):1837-42. PubMed ID: 1832425
    [Abstract] [Full Text] [Related]

  • 13. Functional interaction between B cell subpopulations defined by CD23 expression.
    Armitage RJ, Goff LK.
    Eur J Immunol; 1988 Nov 15; 18(11):1753-60. PubMed ID: 2974422
    [Abstract] [Full Text] [Related]

  • 14. Regulation of Fc epsilon R2/CD23 gene expression by cytokines and specific ligands (IgE and anti-Fc epsilon R2 monoclonal antibody). Variable regulation depending on the cell types.
    Kawabe T, Takami M, Hosoda M, Maeda Y, Sato S, Mayumi M, Mikawa H, Arai K, Yodoi J.
    J Immunol; 1988 Aug 15; 141(4):1376-82. PubMed ID: 2969400
    [Abstract] [Full Text] [Related]

  • 15. CD23 and chronic lymphocytic leukemia.
    Sarfati M.
    Blood Cells; 1993 Aug 15; 19(3):591-6; discussion 597-9. PubMed ID: 8018941
    [Abstract] [Full Text] [Related]

  • 16. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY, Hofstetter H, Banchereau J, Delespesse G.
    J Immunol; 1991 Apr 01; 146(7):2122-9. PubMed ID: 1826018
    [Abstract] [Full Text] [Related]

  • 17. CD20 monoclonal antibodies decrease interleukin-4-stimulated expression of the low-affinity receptor for IgE (Fc epsilon RII/CD23) in human B cells by increasing the extent of its cleavage.
    Bourget I, Di Berardino W, Breittmayer JP, Grenier-Brossette N, Plana-Prades M, Bonnefoy JY, Cousin JL.
    Eur J Immunol; 1995 Jul 01; 25(7):1872-6. PubMed ID: 7542593
    [Abstract] [Full Text] [Related]

  • 18. Cross-linking of membrane IgM on B CLL cells: dissociation between intracellular free Ca2+ mobilization and cell proliferation.
    Hivroz C, Grillot-Courvalin C, Labaume S, Miglierina R, Brouet JC.
    Eur J Immunol; 1988 Nov 01; 18(11):1811-7. PubMed ID: 3144454
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of the low affinity Fc receptor for IgE (Fc epsilon R2/CD23) and the IL-2 receptor (Tac/p55) on eosinophilic leukemia cell line (EoL-1 and EoL-3).
    Hosoda M, Makino S, Kawabe T, Maeda Y, Satoh S, Takami M, Mayumi M, Arai K, Saitoh H, Yodoi J.
    J Immunol; 1989 Jul 01; 143(1):147-52. PubMed ID: 2525145
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide "dual pathway" of signalling.
    Gordon J, Cairns JA, Millsum MJ, Gillis S, Guy GR.
    Eur J Immunol; 1988 Oct 01; 18(10):1561-5. PubMed ID: 2847932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.